Author

Jiayu Ding

China Pharmaceutical UniversityORCID 0000-0001-9264-218XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Dawei WangiD· 1 shared Fei HuangiD· 1 shared Ge DongiD· 1 shared Haiping HaoiD· 1 shared Hang He· 1 shared Hongxi Zhou· 1 shared Jingjing LiuiD· 1 shared Jinxin Jiang· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dawei WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyDisease Models & MechanismsPeer-reviewedJun 12, 2025

Depicting pathogenesis of osteomyelitis by single cell RNA-sequencing and an involvement of Morrbid in the autoinflammatory disease

Qingran Huo, Jiayu Ding, Hongxi Zhou…·Zhigang Cai

This study uses scRNA-seq to show that loss of Morrbid reduces osteoclasts and inflammation in a mouse model of CRMO, suggesting it as a therapeutic target for osteomyelitis.

2 citations

mousescRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 7, 2024

Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy

Wenbin Kuang, Jinxin Jiang, Xiao Wang…·Peng Yang

This study identifies PTPN2 as a therapeutic target in AML, discovers a selective inhibitor K73, and demonstrates its efficacy in reducing AML burden in vitro and in vivo.

2 citations

humanexperimental assay

𝕏 PostBluesky